Cargando…
A public health timeline to prepare for COVID-19 vaccines in Canada
For control of COVID-19, community immunity is required, necessitating widespread immunization. COVID-19 vaccines are coming to Canada, with the government announcing in August 2020 agreements with four different companies for their COVID-19 vaccine if their trials are successful. Never before has p...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643523/ https://www.ncbi.nlm.nih.gov/pubmed/33151510 http://dx.doi.org/10.17269/s41997-020-00423-1 |
_version_ | 1783606294723166208 |
---|---|
author | MacDonald, Noni E. Comeau, Jeannette Dubé, Eve Bucci, Lucie Graham, Janice E. |
author_facet | MacDonald, Noni E. Comeau, Jeannette Dubé, Eve Bucci, Lucie Graham, Janice E. |
author_sort | MacDonald, Noni E. |
collection | PubMed |
description | For control of COVID-19, community immunity is required, necessitating widespread immunization. COVID-19 vaccines are coming to Canada, with the government announcing in August 2020 agreements with four different companies for their COVID-19 vaccine if their trials are successful. Never before has public health had to rapidly develop a vaccine introduction program for multiple new but differing vaccines with the added pressure that the program is needed across all ages and in all Canadian communities and there is high probability of not enough vaccine to go around at the start. Traditional public health vaccine introduction planning will need to be both accelerated and more comprehensive to ensure optimal uptake across the country. This overview highlights a number of points for consideration by public health in their planning for COVID-19 vaccines before these COVID-19 vaccines are available, once they are available, once supplies are plentiful, and throughout the vaccine program. Targeted and tailored communications are key elements needed to reach and positively influence diverse communities, regions, ages, languages, education levels and lived experiences. |
format | Online Article Text |
id | pubmed-7643523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-76435232020-11-05 A public health timeline to prepare for COVID-19 vaccines in Canada MacDonald, Noni E. Comeau, Jeannette Dubé, Eve Bucci, Lucie Graham, Janice E. Can J Public Health Special Section on COVID-19: Commentary For control of COVID-19, community immunity is required, necessitating widespread immunization. COVID-19 vaccines are coming to Canada, with the government announcing in August 2020 agreements with four different companies for their COVID-19 vaccine if their trials are successful. Never before has public health had to rapidly develop a vaccine introduction program for multiple new but differing vaccines with the added pressure that the program is needed across all ages and in all Canadian communities and there is high probability of not enough vaccine to go around at the start. Traditional public health vaccine introduction planning will need to be both accelerated and more comprehensive to ensure optimal uptake across the country. This overview highlights a number of points for consideration by public health in their planning for COVID-19 vaccines before these COVID-19 vaccines are available, once they are available, once supplies are plentiful, and throughout the vaccine program. Targeted and tailored communications are key elements needed to reach and positively influence diverse communities, regions, ages, languages, education levels and lived experiences. Springer International Publishing 2020-11-05 /pmc/articles/PMC7643523/ /pubmed/33151510 http://dx.doi.org/10.17269/s41997-020-00423-1 Text en © The Canadian Public Health Association 2020 |
spellingShingle | Special Section on COVID-19: Commentary MacDonald, Noni E. Comeau, Jeannette Dubé, Eve Bucci, Lucie Graham, Janice E. A public health timeline to prepare for COVID-19 vaccines in Canada |
title | A public health timeline to prepare for COVID-19 vaccines in Canada |
title_full | A public health timeline to prepare for COVID-19 vaccines in Canada |
title_fullStr | A public health timeline to prepare for COVID-19 vaccines in Canada |
title_full_unstemmed | A public health timeline to prepare for COVID-19 vaccines in Canada |
title_short | A public health timeline to prepare for COVID-19 vaccines in Canada |
title_sort | public health timeline to prepare for covid-19 vaccines in canada |
topic | Special Section on COVID-19: Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643523/ https://www.ncbi.nlm.nih.gov/pubmed/33151510 http://dx.doi.org/10.17269/s41997-020-00423-1 |
work_keys_str_mv | AT macdonaldnonie apublichealthtimelinetoprepareforcovid19vaccinesincanada AT comeaujeannette apublichealthtimelinetoprepareforcovid19vaccinesincanada AT dubeeve apublichealthtimelinetoprepareforcovid19vaccinesincanada AT buccilucie apublichealthtimelinetoprepareforcovid19vaccinesincanada AT grahamjanicee apublichealthtimelinetoprepareforcovid19vaccinesincanada AT macdonaldnonie publichealthtimelinetoprepareforcovid19vaccinesincanada AT comeaujeannette publichealthtimelinetoprepareforcovid19vaccinesincanada AT dubeeve publichealthtimelinetoprepareforcovid19vaccinesincanada AT buccilucie publichealthtimelinetoprepareforcovid19vaccinesincanada AT grahamjanicee publichealthtimelinetoprepareforcovid19vaccinesincanada |